GRABACIN-3 TULLE

Indications

• Bacterial infections
• Pneumonia
• Urinary tract infections
• Skin and soft tissue infections
• Sepsis
• Gastrointestinal infections
• Bone and joint infections

Dosage

Children: Refer to specific pediatric dosing guidelines and product information for age-appropriate dosing.

Adults: Refer to specific antibiotic guidelines and product information for appropriate dosing recommendations.

Mechanism of action

Antibiotics exert their effects through various mechanisms depending on their class. For example, beta-lactam antibiotics, such as penicillins and cephalosporins, inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis. Tetracyclines inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit, while aminoglycosides also target protein synthesis but by binding to the 30S and causing misreading of mRNA. Fluoroquinolones inhibit DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication.

Pharmacodynamics

The pharmacodynamic properties of antibiotics involve their ability to kill bacteria (bactericidal) or inhibit their growth (bacteriostatic). The efficacy of an antibiotic is often determined by its minimum inhibitory concentration (MIC) against the target organism. The post-antibiotic effect, which is the continued suppression of bacterial growth after the antibiotic concentration falls below the MIC, can also play a role in their effectiveness.

Pharmacokinetics

The pharmacokinetics of antibiotics includes absorption, distribution, metabolism, and excretion (ADME). Most antibiotics are absorbed in the gastrointestinal tract, with bioavailability varying by drug class. They are widely distributed in body tissues and fluids. Some antibiotics are metabolized in the liver, while others are excreted unchanged by the kidneys. This pharmacokinetic profile influences dosing regimens, particularly in patients with renal impairment.

Contra-indications

• Hypersensitivity to the antibiotic or any of its components
• Severe renal impairment (specific antibiotics may vary)
• History of antibiotic-associated colitis

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Rash
• Allergic reactions (e.g., anaphylaxis)
• Hepatotoxicity
• Nephrotoxicity
• Superinfection (such as Clostridium difficile infection)

Interactions

• Antacids may reduce the absorption of certain antibiotics
• Probenecid may increase the plasma concentration of some antibiotics
• Warfarin may have increased anticoagulant effects
• Oral contraceptives may be less effective when combined with certain antibiotics

Precautions

• Use with caution in patients with a history of gastrointestinal disease
• Monitor for signs of anaphylaxis after the first dose
• Assess renal function prior to use for those with pre-existing conditions
• Consider the potential for antibiotic resistance

Pregnancy

Generally considered safe in pregnancy; however, specific antibiotics may have limitations or risks, consult relevant guidelines.

Breast-feeding

Many antibiotics are excreted in breast milk; consult specific guidelines for safety during lactation.

Storage

Store in a cool, dry place away from direct sunlight. Some formulations may require refrigeration.

Formulations

• Tablets
• Capsules
• Liquid suspensions
• Injectable forms
• Topical preparations

Indications

• Acute wounds
• Chronic wounds
• Surgical wounds
• Burns
• Pressure ulcers
• Infected wounds

Dosage

Children: The use of dressings in children should be guided by the type and nature of the wound. Refer to specific product guidelines for detailed application instructions.

Adults: The application of dressings should be based on the type and severity of the wound. Refer to specific product guidelines for detailed application instructions.

Mechanism of action

Dressings act by providing a barrier to external contaminants, maintaining a moist wound environment, and facilitating gas exchange. Certain types, such as hydrocolloids, form a gel-like substance upon contact with wound exudate, which aids in autolytic debridement and promotes healing. Antimicrobial dressings release agents that inhibit microbial growth, contributing to infection prevention.

Pharmacodynamics

The pharmacodynamics of dressings depend on their specific characteristics. Hydrocolloid and foam dressings maintain moisture and support autolytic debridement, while alginate dressings can absorb significant amounts of exudate. Antimicrobial dressings release active agents that target pathogens, reducing the risk of infection. The interaction between the dressing material and the wound environment influences healing rates and outcomes.

Pharmacokinetics

Dressings do not have systemic pharmacokinetics since they are applied topically and act locally at the site of application. The duration of action varies based on the type of dressing, the wound's exudate level, and the specific materials used. Changes in the dressing may be required based on the wound's condition and healing progress.

Pregnancy

Generally considered safe for use during pregnancy, but specific type of dressing should be assessed based on clinical need and patient condition.

Breast-feeding

Generally safe for use while breastfeeding, but care should be taken to ensure the dressing does not irritate the skin or affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep in original packaging until use to maintain sterility.

Formulations

• Hydrocolloid dressings
• Foam dressings
• Alginate dressings
• Transparent film dressings
• Hydrogel dressings
• Gauze dressings

Indications

• Acute wounds
• Chronic wounds
• Surgical incisions
• Burns
• Pressure ulcers
• Trauma wounds

Dosage

Children: Refer to the guidance for adult dosing, as pediatric use is similar and should be based on clinical assessment of the wound and exudate.

Adults: The dosage or application frequency of gauze depends on the specific wound type and the amount of exudate. It is typically changed as needed, based on clinical assessment.

Mechanism of action

Gauze functions primarily as a physical barrier to protect wounds from external contaminants and further injury. It absorbs exudate from wounds, which helps to maintain a moist environment conducive to healing. The open weave of gauze allows for breathability, which is essential in preventing maceration of the surrounding skin.

Pharmacodynamics

As a non-pharmacological product, gauze does not have pharmacodynamic properties in the traditional sense. Its effectiveness is related to its physical characteristics, such as absorbency, flexibility, and ability to protect wounds. The interaction with the wound environment aids in managing exudate and reducing the risk of infection.

Pharmacokinetics

Gauze does not undergo pharmacokinetic processes such as absorption, distribution, metabolism, or excretion, as it is not an active pharmaceutical ingredient. Instead, it provides a mechanical function in wound management. The duration of action is dependent on the frequency of dressing changes, which is influenced by the amount of exudate produced by the wound.

Pregnancy

Gauze is considered safe for use during pregnancy as it is a non-pharmacological material used primarily for wound care.

Breast-feeding

Gauze is safe for use during breastfeeding, as it is unlikely to affect breast milk or the nursing infant.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Ensure that the packaging remains sealed until use to prevent contamination.

Formulations

• Sterile gauze pads
• Non-sterile gauze pads
• Gauze rolls

Indications

• Eczema
• Minor excoriations
• Wounds
• Hemorrhoids
• Sunburn prevention

Dosage

Children: Consult the BNF for Children for appropriate dosing information based on age and condition.

Adults: Apply to the affected area as needed, ensuring the skin is clean and dry before application. Refer to specific product guidelines for frequency.

Mechanism of action

Triple acts by providing a physical barrier to prevent skin irritation and help heal damaged skin. When inhaled, zinc oxide fumes can initiate pro-inflammatory responses in the lungs, leading to conditions such as metal fume fever by increasing pulmonary neutrophils and the release of tumor necrosis factor (TNF) and interleukins.

Pharmacodynamics

Zinc oxide exhibits astringent, soothing, and protective properties. Its topical applications are effective for various skin conditions, including eczema and minor wounds. The substance also has the ability to reflect ultraviolet radiation, making it useful in sunscreens and protection against sunburn.

Pharmacokinetics

Zinc oxide is minimally absorbed through the skin when used topically, thus its systemic effects are negligible. When inhaled, the fine particles can affect lung tissue but are typically of low concern when used as intended in topical formulations. The onset of local effects is rapid due to its barrier properties.

Adverse effects

• skin irritation
• allergic reactions
• respiratory distress if inhaled

Precautions

• Avoid inhalation of fumes, especially in poorly ventilated areas.
• Use with caution in patients with a history of allergies to zinc or other components.

Pregnancy

Zinc oxide is generally considered safe for use during pregnancy. However, it is advisable to consult a healthcare provider before use.

Breast-feeding

Zinc oxide is considered safe during breastfeeding, but it is recommended to consult a healthcare provider for individual cases.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• topical creams
• ointments
• powders

Mechanism of action

It acts by providing a physical barrier to prevent skin irritation and help heal damaged skin. ... Freshly formed fumes are ... composed of ... particles in range of 0.05 to 0.5 um, and ... /have/ increased activity when they come into contact with the alveolar walls of lung. As fumes age they become less reactive because they tend to agglomerate or form aggregates and settle out of atmosphere ... thereby reducing concn of reactive particulates in lung. ... The size of particles is important factor in producing the illness. ... Finely divided particles of metals /are/ so small that they behave much like a gas and act on the alveolar surfaces, affecting the lung tissue and not upper respiratory tract. /Zinc/ ... /That/ zinc oxide fume inhalation initiates a time-dependent sequence of proinflammatory events /was postulated/. This includes dose-dependent increases in pulmonary neutrophils and increased tumor necrosis factor (TNF) release into the pulmonary environment beginning at 3 hr after exposure, which, in turn, may lead to increases in bronchoalveolar lavage (BAL) IL-6 and the neutrophil chemoattractant IL-8. The IL-6 then enters the circulation, contributing to the development of the fever and the symptoms of metal-fume fever. /It was/ confirmed, through in vitro studies, that zinc oxide exposure stimulated U937 mononuclear cells to release TNF and IL-8, a finding consistent with in vivo observations in metal-fume fever. The pathogenesis /of metal fume fever/ is unknown, but it is thought to result from endogenous pyrogen release due to cell lysis. Extracts prepared from tracheal mucosa and from the lungs of animals with experimentally induced metal fume fever produce similar symptoms when injected into other animals. Diminish the penetration of ultraviolet (UV) light through the epidermis by absorbing UV radiation within a specific wavelength range. The amount and wavelength of UV radiation absorbed are affected by the molecular structure of the sunscreen agent. /Sunscreen agents/

Pharmacodynamics

Zinc oxide has astringent, soothing and protective properties and is used in topical preparations for eczema, slight excoriations, wounds and haemorrhoids. It also reflects ultraviolet radiation and can be used as a physical sunscreen.